Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05122663 · ClinicalTrials.gov registry record
Emergency Department Vestibular Rehabilitation Therapy for Dizziness and Vertigo
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 125
- Enrollment target
NCT05122663: Completed study, sponsored by Northwestern University.
NCT05122663 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05122663 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
ED-VeRT will enroll up to 125 adult emergency department (ED) patients presenting with a chief complaint of dizziness or vertigo to collect longitudinal outcomes over 3 months of follow-up. This will include 50 patients who were evaluated by an ED physical therapist (ie, vestibular rehabilitation) during their ED visit and 50 patients who received usual care. The aims of this trial are to: (1) obtain initial estimates of participant recruitment and retention, intra-cluster correlation, and between-group outcome differences that will inform sample size calculation for a future randomized clinical trial, and (2) assess feasibility and fidelity of a clinical classification protocol for undifferentiated dizziness among patients receiving ED vestibular rehabilitation.
Primary Outcome
The DHI contains 25 items quantifying self-perceived handicapping effects of dizziness symptoms.
Interventions
- OTHER Usual Care
- BEHAVIORAL Vestibular Rehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2021-11-16 |
| Est. Completion | 2023-05-01 |
What the finished NCT05122663 record still lists
NCT05122663 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT05122663 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05122663 about?
NCT05122663 is a clinical study titled "Emergency Department Vestibular Rehabilitation Therapy for Dizziness and Vertigo". ED-VeRT will enroll up to 125 adult emergency department (ED) patients presenting with a chief complaint of dizziness or vertigo to collect longitudinal outcomes over 3 months of follow-up. This will include 50 patients who were evaluated by an ED physical therapist (ie, vestibular rehabilitation) d...
What is the current status of trial NCT05122663?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2021-11-16. Estimated completion is 2023-05-01.
What interventions are being tested in trial NCT05122663?
The interventions under investigation include: Usual Care (OTHER), Vestibular Rehabilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05122663?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI